Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Cambio

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Urology|August 12, 2005
Recent developments in advanced urothelial cancerKaren Giselle Chee, Angelo Cambio, Primo N Lara
The Prostate|December 10, 2009
The impact of HMG-CoA reductase therapy on serum PSADavid J Mener, Angelo Cambio, David G Stoddard, et al.
The Journal of Urology|August 30, 2008
Development and validation of the fecal incontinence and constipation quality of life measure in children with spina bifidaDana K Nanigian, Thuan Nguyen, Stacy T Tanaka, et al.
Clinical Genitourinary Cancer|February 15, 2008
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trialKaren G Chee, Jeff Longmate, David I Quinn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Urology|August 12, 2005
Recent developments in advanced urothelial cancerKaren Giselle Chee, Angelo Cambio, Primo N Lara
The Prostate|December 10, 2009
The impact of HMG-CoA reductase therapy on serum PSADavid J Mener, Angelo Cambio, David G Stoddard, et al.
The Journal of Urology|August 30, 2008
Development and validation of the fecal incontinence and constipation quality of life measure in children with spina bifidaDana K Nanigian, Thuan Nguyen, Stacy T Tanaka, et al.
Clinical Genitourinary Cancer|February 15, 2008
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trialKaren G Chee, Jeff Longmate, David I Quinn, et al.
Pageof 1